Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma: results from the DIRECTOR trial
AbstractBackground. The role of reoperation for recurrent glioblastoma (GBM) remains unclear. Prospective studies are lacking. Here, we studied the association
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
27 January 2016
|
| In: |
Neuro-Oncology
Year: 2016, Jahrgang: 18, Heft: 4, Pages: 549-556 |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/nov326 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1093/neuonc/nov326 Verlag, Volltext: https://academic.oup.com/neuro-oncology/article/18/4/549/2509360 |
| Verfasserangaben: | Bogdana Suchorska, Michael Weller, Ghazaleh Tabatabai, Christian Senft, Peter Hau, Michael C. Sabel, Ulrich Herrlinger, Ralf Ketter, Uwe Schlegel, Christine Marosi, Guido Reifenberger, Wolfgang Wick, Jörg C. Tonn, and Hans-Georg Wirsching |
| Zusammenfassung: | AbstractBackground. The role of reoperation for recurrent glioblastoma (GBM) remains unclear. Prospective studies are lacking. Here, we studied the association |
|---|---|
| Beschreibung: | Gesehen am 11.02.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1523-5866 |
| DOI: | 10.1093/neuonc/nov326 |